EUVIMEDEUVIMED entdecken
Crossref

Patients with restless legs syndrome exhibit reduced serum colony-stimulating factor-1, humanin-like 3 and 10 levels

Asena Gülçiçek, Elif Şanlı, Gülçin Benbir Şenel, Derya Karadeniz, Özlem Timirci-Kahraman, Cem İsmail Küçükali, Erdem Tüzün

Acta Neurologica Belgica · 2024

DOI: 10.1007/s13760-024-02549-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Neurologica Belgica, 2024. Verfasst von Asena Gülçiçek und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroscience, Institute of Graduate Studies in Health Sciences, Aziz Sancar Institute of Experimental Medicine, Istanbul University, Is…. Hauptthemen laut MEDLINE: Restless Legs Syndrome. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: Bilimsel Araştirma Projeleri Birimi, Istanbul Üniversitesi.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: The main pathophysiological mechanisms in restless legs syndrome (RLS) are known as genetic predisposition, brain iron deficiency, and dopaminergic dysfunction. While some genetic variants and polymorphisms were defined, the genetic basis and etiopathogenesis of RLS remain unclear. We aimed to identify new candidate genes and/or potential biomarkers associated with increased RLS risk. METHODS: Twenty-three patients with RLS, 30 patients with Parkinson's disease (PD), and 27 healthy controls were enrolled. Agilent Human 8X60K Oligo Microarray was used for the identification of gene expression levels in peripheral blood cells. Gene ontology (GO) analysis was used for functional annotation of differentially expressed genes (DEGs). Serum levels of selected DEGs were measured by ELISA for validation. RESULTS: Patients with RLS showed 30 downregulated DEGs compared to healthy controls. Two genes, MTRNR2L10 and MTRNR2L3, involved negative regulation of the execution phase of apoptosis were highlighted in GO analysis. These genes encode humanin-like 10 and 3, respectively, were encoded by these genes, and their levels, along with CSF-1, linked to neurodegeneration, were reduced in RLS patients. Humanin-like 10 and CSF-1 levels correlated with sleep efficiency and N2 sleep duration, while humanin-like 3 levels correlated with mean sleep oxygen saturation during sleep. CONCLUSION: Our study showed that several neuroprotective genes were downregulated in RLS, which may confer susceptibility to neuronal death associated with decreased sleep efficiency. Microarray results differed between RLS and PD patients, suggesting diverse pathogenetic mechanisms. CSF-1, which is involved in iron, dopamine metabolism, and blood oxygenation, appears to partake in RLS pathophysiology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Restless Legs SyndromeHumansFemaleMaleMiddle AgedAgedBiomarkersParkinson DiseaseAdult

Stichwörter der Autor:innen

Colony stimulating factor-1Humanin-likeMicroarrayParkinson’s diseaseRestless legs syndrome

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Department of Neuroscience, Institute of Graduate Studies in Health Sciences, Aziz Sancar Institute of Experimental Medicine, Istanbul University, Istanbul, Turkey. gulcicekasena1@gmail.com.
  • Department of Neuroscience, Institute of Graduate Studies in Health Sciences, Aziz Sancar Institute of Experimental Medicine, Istanbul University, Istanbul, Turkey.
  • Sleep and Disorders Unit, Division of Clinical Neurophysiology, Department of Neurology, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, Türkiye.
  • Department of Molecular Medicine, Aziz Sancar Institute of Experimental Medicine, Istanbul University, Istanbul, Turkey.

Förderung

  • Bilimsel Araştirma Projeleri Birimi, Istanbul Üniversitesi

Zitieren

APA

Gülçiçek, A., Şanlı, E., Şenel, G. B., Karadeniz, D., Timirci-Kahraman, Ö., Küçükali, C. İ., & Tüzün, E. (2024). Patients with restless legs syndrome exhibit reduced serum colony-stimulating factor-1, humanin-like 3 and 10 levels. Acta Neurologica Belgica. https://doi.org/10.1007/s13760-024-02549-2

Vancouver

Gülçiçek A, Şanlı E, Şenel GB, Karadeniz D, Timirci-Kahraman Ö, Küçükali Cİ, et al. Patients with restless legs syndrome exhibit reduced serum colony-stimulating factor-1, humanin-like 3 and 10 levels. Acta Neurologica Belgica. 2024. doi:10.1007/s13760-024-02549-2

BibTeX
@article{Gliek2024,
  author = {Gülçiçek, Asena and Şanlı, Elif and Şenel, Gülçin Benbir and Karadeniz, Derya and Timirci-Kahraman, Özlem and Küçükali, Cem İsmail and Tüzün, Erdem},
  title = {Patients with restless legs syndrome exhibit reduced serum colony-stimulating factor-1, humanin-like 3 and 10 levels},
  journal = {Acta Neurologica Belgica},
  year = {2024},
  doi = {10.1007/s13760-024-02549-2}
}
Kostenlos starten →